Washington University School of Medicine in St. Louis has received a grant from the Centers for Disease Control and Prevention (CDC) to evaluate the effectiveness of vaccines against the SARS-CoV-2 virus among health-care personnel on the WashU Medical Campus and across BJC HealthCare. The study, which includes 16 sites across the country, will allow for the rapid evaluation of these vaccines in a real-world setting with high exposure to the virus.
